Trial Profile
The impact of different durations of insulin treatment [insulin neutral protamine lispro/insulin lispro] on beta islet-cell function in newly diagnosed type 2 Diabetes after short-term intensive insulin therapy.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2011
Price :
$35
*
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 19 Oct 2011 New trial record